LivaNova (LIVN) Debt Ratio (2015 - 2026)
LivaNova recorded quarterly Debt Ratio of 0.11 in Q1 2026, down 20.87% quarter-over-quarter from 0.14 in Q4 2025, and down 53.46% year-over-year from 0.25 in Q1 2025.
LivaNova's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.11 for Q1 2026.
- In Q1 2026, Debt Ratio fell 53.46% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (down 53.46% YoY), while the FY2025 annual figure was 0.14, down 42.28% from the prior year.
- Debt Ratio came in at 0.11 for Q1 2026 at LivaNova, down from 0.14 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.73 in Q2 2024 to a low of 0.11 in Q1 2026.
- A 5-year average of 0.25 and a median of 0.24 in 2023 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio jumped 231.49% in 2022 and tumbled 78.35% in 2025, its largest moves.
- LivaNova's Debt Ratio stood at 0.24 in 2022, then rose by 2.33% to 0.24 in 2023, then rose by 3.71% to 0.25 in 2024, then sank by 42.28% to 0.14 in 2025, then retreated by 20.87% to 0.11 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.11, 0.14, and 0.17 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 0.25 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | 0.25 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.24 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.24 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.19 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.25 |
| Mar 31, 2021 | 0.28 |
| Dec 31, 2020 | 0.27 |
| Sep 30, 2020 | 0.26 |
| Jun 30, 2020 | 0.26 |
| Mar 31, 2020 | 0.22 |
| Dec 31, 2019 | 0.14 |
| Sep 30, 2019 | 0.14 |
| Jun 30, 2019 | 0.08 |
| Mar 31, 2019 | 0.07 |
| Dec 31, 2018 | 0.07 |
| Sep 30, 2018 | 0.06 |
| Jun 30, 2018 | 0.06 |
| Mar 31, 2018 | 0.07 |
| Dec 31, 2017 | 0.06 |
| Sep 30, 2017 | 0.05 |
| Jun 30, 2017 | 0.05 |
| Mar 31, 2017 | 0.05 |
| Dec 31, 2016 | 0.05 |
| Sep 30, 2016 | 0.06 |
| Jun 30, 2016 | 0.06 |
| Mar 31, 2016 | 0.07 |
| Dec 31, 2015 | 0.07 |